NMDA receptor activation by HIV-Tat protein is clade dependent

Area of Science:

• Neuroscience
• Virology
• Immunology

Background:

• HIV-associated dementia (HAD) severity varies globally, with clade B infections causing more severe neurological symptoms than clade C.
• HIV-infected macrophages are key mediators of HAD, releasing toxic proteins like Tat.
• Tat protein's neurotoxicity is implicated in cognitive impairment, but its interaction with neuronal receptors and clade-specific differences are not fully understood.

Purpose of the Study:

• To investigate the clade-dependent neurotoxicity of HIV Tat protein.
• To determine if Tat protein interacts with NMDA receptors and mediates excitotoxicity.
• To elucidate the molecular mechanisms underlying clade-specific Tat neurotoxicity.

Main Methods:

• Molecular modeling and site-directed mutagenesis were used to study Tat protein interactions.
• Experiments were conducted to assess Tat protein binding to NMDA receptors.
• Neurotoxicity assays were performed using Tat-expressing cells and recombinant Tat protein.

Main Results:

• HIV Tat protein directly binds to the NMDA receptor, leading to excitotoxicity.
• The Cys 30-Cys 31 motif in Tat is crucial for NMDA receptor activation.
• A Cys31Ser mutation in clade C Tat significantly attenuates neurotoxicity by disrupting NMDA receptor disulfide bonds.

Conclusions:

• HIV Tat protein's neurotoxicity is mediated by direct interaction with the NMDA receptor.
• Clade-specific differences in Tat protein, particularly the Cys31Ser mutation in clade C, significantly impact neurotoxicity.
• Understanding these molecular interactions is crucial for developing therapeutic strategies against HAD.